Lumigan

In some countries, this medicine may only be approved for veterinary use.

In the US, Lumigan (bimatoprost ophthalmic) is a member of the drug class ophthalmic glaucoma agents and is used to treat Glaucoma - Open Angle and Intraocular Hypertension.

US matches:

• Lumigan


• Lumigan Drops

UK matches:

• Lumigan
• Lumigan 0.1mg/ml
• Lumigan 0.3mg/ml eye drops, solution (SPC)

Ingredient matches for Lumigan

Bimatoprost

Bimatoprost is reported as an ingredient of Lumigan in the following countries:

• Argentina


• Australia


• Austria


• Belgium


• Brazil


• Canada


• Chile


• Colombia


• Costa Rica


• Croatia (Hrvatska)


• Czech Republic


• Denmark


• El Salvador


• Finland


• France


• Germany


• Greece


• Guatemala


• Hong Kong


• Hungary


• Iceland


• Ireland


• Israel


• Italy


• Luxembourg


• Malaysia


• Mexico


• Netherlands


• New Zealand


• Norway


• Panama


• Peru


• Poland


• Portugal


• Singapore


• Slovakia


• Slovenia


• South Africa


• Spain


• Sweden


• Switzerland


• Taiwan


• Thailand


• Tunisia


• Turkey


• United Kingdom


• United States


• Venezuela

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.